Compare GLP-1 Drugs: The Clinical Showdown
Which medication works better? We analyze the head-to-head clinical trial data (SURMOUNT-5), weight loss percentages, and side-effect profiles of Mounjaro, Ozempic, Wegovy, and Zepbound.
Compare Providers →Featured Guides
Curated by our Editorial BoardThe Dual-Agonist Advantage
Is two better than one? This video explains the difference between a single agonist (Ozempic/Wegovy targets GLP-1 only) and a dual agonist (Mounjaro/Zepbound targets GLP-1 and GIP). The data shows that hitting both receptors often results in significantly higher weight loss and potentially better metabolic handling.
Medical Fact-Check
Ozempic vs Mounjaro: Weight Loss, Dosing & Cost
Ozempic vs Mounjaro: both can deliver meaningful weight loss; tirzepatide often shows larger averages at maintenance doses. This guide explains dosing, side effects, and the “Price Trio” so you can estimate Month-1, Month-2+, and medication costs and choose what fits.
Medical Fact-Check
Switching from Ozempic to Mounjaro – Expert GLP-1 Guide
Ozempic not working as hoped? Switching from Ozempic to Mounjaro might boost your results. Learn the benefits, risks, and how to switch safely.
Swipe to see more guides
Explore Other Topics
Deep dive into specific guidesStart Here
Understanding "Food Noise," the biology of GLP-1s, and what to expect in Month 1.
Read Guide
Pricing & Compare
The real cost of Wegovy vs. Zepbound. Hidden fees and insurance copays.
View Costs
Insurance & Coverage
How to fight a "Prior Auth" denial and check coverage rules.
Check Coverage
Safety & Side Effects
Nausea, "Ozempic Face," and long-term risks. Fact vs. Fiction.
Safety Info
Switching & Refills
Finding stock during a shortage and how to safely switch brands.
Switching Steps
You're Here
Brands & Comparisons
Mounjaro vs. Ozempic vs. Wegovy. Head-to-head comparisons.
Compare Brands
Swipe to explore topics
Common Questions
Mounjaro vs. Ozempic: Which is better for weight loss?
In the Mounjaro vs Ozempic weight loss comparison, Mounjaro (tirzepatide) statistically outperforms Ozempic (semaglutide). The 2025 SURMOUNT-5 head-to-head trial was definitive: participants on Zepbound (Mounjaro) lost an average of 20.2% of their body weight, compared to 13.7% for those on Wegovy (Ozempic). Furthermore, Zepbound users were significantly more likely to achieve "super-responder" status (losing >25% of body weight).
What is the difference between Wegovy and Zepbound?
While both are weekly injectables for obesity, they use different molecules with different mechanisms.
Wegovy (Semaglutide): Mimics one hormone (GLP-1). It is the incumbent, proven effective, and widely covered by insurance.
Zepbound (Tirzepatide): Mimics two hormones (GLP-1 and GIP). Wegovy vs Zepbound efficacy data suggests Zepbound is more potent. The addition of GIP appears to tackle metabolic dysregulation from a second angle, potentially improving insulin sensitivity and fat metabolism more aggressively than GLP-1 alone.
Wegovy (Semaglutide): Mimics one hormone (GLP-1). It is the incumbent, proven effective, and widely covered by insurance.
Zepbound (Tirzepatide): Mimics two hormones (GLP-1 and GIP). Wegovy vs Zepbound efficacy data suggests Zepbound is more potent. The addition of GIP appears to tackle metabolic dysregulation from a second angle, potentially improving insulin sensitivity and fat metabolism more aggressively than GLP-1 alone.
Is Tirzepatide stronger than Semaglutide?
Yes. Clinical data supports that tirzepatide vs semaglutide shows superior efficacy across almost all weight loss metrics. The synergy of the GIP (Glucose-dependent Insulinotropic Polypeptide) receptor agonist with the GLP-1 agonist allows for a more comprehensive "reset" of the body's set point. In the SURMOUNT-5 trial, the tirzepatide group achieved nearly 50% greater relative weight loss than the semaglutide group.
Which drug has fewer side effects?
Paradoxically, despite being "stronger," Zepbound (tirzepatide) often has a similar or slightly better tolerability profile compared to Wegovy. In head-to-head studies, the rates of nausea, vomiting, and diarrhea were comparable between the two groups.
Some researchers hypothesize that the GIP component might actually have an anti-emetic (anti-nausea) effect that counteracts the GLP-1 nausea, allowing patients to tolerate higher effective doses. However, individual response varies; some patients tolerate Semaglutide perfectly but cannot handle Tirzepatide.
Some researchers hypothesize that the GIP component might actually have an anti-emetic (anti-nausea) effect that counteracts the GLP-1 nausea, allowing patients to tolerate higher effective doses. However, individual response varies; some patients tolerate Semaglutide perfectly but cannot handle Tirzepatide.
What is the best GLP-1 for weight loss if I don't have diabetes?
The best GLP-1 for weight loss currently approved by the FDA for non-diabetics are Wegovy (semaglutide) and Zepbound (tirzepatide). Between the two, Zepbound is the statistical winner in terms of raw weight loss percentages (20.2% vs 13.7%).
However, the "best" drug is often the one you can actually get. Wegovy has been on the market longer and may have broader formulary coverage. Zepbound, being newer, may face stricter Prior Authorization hurdles or higher copays. Ultimately, the best drug is the one your insurance covers and that you can find in stock.
However, the "best" drug is often the one you can actually get. Wegovy has been on the market longer and may have broader formulary coverage. Zepbound, being newer, may face stricter Prior Authorization hurdles or higher copays. Ultimately, the best drug is the one your insurance covers and that you can find in stock.
Independently Verified: We review provider licensing, pricing transparency, and BBB standing monthly.
See our standards